Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (261-270 of 332) with videos related to

Pageof 34
Sort By:
Clinical Genitourinary Cancer|December 12, 2018
Imaging in Suspected Renal-Cell Carcinoma: Systematic ReviewChristina Vogel, Brigitte Ziegelmüller, Börje Ljungberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2019
Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancerCharlotte S Voskuilen, Judith Bosschieter, Erik van Werkhoven, et al.
European Urology|December 18, 2021
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology|December 28, 2020
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology Oncology|October 28, 2020
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR ConsortiumYasmin Abu-Ghanem, Thomas Powles, Umberto Capitanio, et al.
European Urology|May 23, 2018
Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled AnalysisMaxine Sun, Lorenzo Marconi, Tim Eisen, et al.
European Urology|September 2, 2015
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour BiopsyLorenzo Marconi, Saeed Dabestani, Thomas B Lam, et al.
European Urology|March 29, 2022
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 UpdateBörje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal CancerGrant D Stewart, Fiach C O'Mahony, Alexander Laird, et al.
European Urology|September 5, 2018
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell CarcinomaAxel Bex, Laurence Albiges, Börje Ljungberg, et al.
Pageof 34

Showing results (261-270 of 332) with videos related to

Sort By:
Pageof 34
Clinical Genitourinary Cancer|December 12, 2018
Imaging in Suspected Renal-Cell Carcinoma: Systematic ReviewChristina Vogel, Brigitte Ziegelmüller, Börje Ljungberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2019
Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancerCharlotte S Voskuilen, Judith Bosschieter, Erik van Werkhoven, et al.
European Urology|December 18, 2021
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology|December 28, 2020
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology Oncology|October 28, 2020
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR ConsortiumYasmin Abu-Ghanem, Thomas Powles, Umberto Capitanio, et al.
European Urology|May 23, 2018
Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled AnalysisMaxine Sun, Lorenzo Marconi, Tim Eisen, et al.
European Urology|September 2, 2015
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour BiopsyLorenzo Marconi, Saeed Dabestani, Thomas B Lam, et al.
European Urology|March 29, 2022
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 UpdateBörje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal CancerGrant D Stewart, Fiach C O'Mahony, Alexander Laird, et al.
European Urology|September 5, 2018
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell CarcinomaAxel Bex, Laurence Albiges, Börje Ljungberg, et al.
Pageof 34